TBPMF News and Press, Tetra Bio-Pharma Inc From 08/27/20

Tetra defines CBD Metabolism in Humans Following QIXLEEF ™ Inhalation Data from metabolite study provides explanation for inhalation as a safe route of administration OTTAWA, ON / ACCESSWIRE / August 27, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX:...

Significant advancement achieved with ARDS-003 sterile injectable nano-emulsion finished drug product A new anti-inflammatory drug candidate OTTAWA, ON / ACCESSWIRE / August 18, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX-V:TBP ) ( OTCQB:TBPMF ), a leader in can...

MONTREAL, QC / ACCESSWIRE / August 17, 2020 / Mondias Natural Products Inc. ( TSXV:NHP ) (the "Company" or "Mondias") specializing in evidence-based natural products for the healthcare and bio-agriculture markets and Tetra Bio-Pharma Inc. ("Tetra") , ( TSX-V:TBP ) ( OTCQB:TBPMF ), a b...

OTTAWA, ON / ACCESSWIRE / August 7, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP ) (OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and development, is pleased to announce that TBP common shares and warrants are now listed on the TSX (the "Common Shares"...

Please disregard original release sent out and replace with the following. Tetra is accelerating its European activities Tetra's European project receives the approval and support from Malta Enterprise OTTAWA, ON / ACCESSWIRE / August 6, 2020 / Tetra Bio-Pharma Inc. ("Tetra" ...

Tetra is accelerating its European activities Tetra's European project receives the approval and support from Malta Enterprise OTTAWA, ON / ACCESSWIRE / August 6, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX-V: TBP ) (OTCQB: TBPMF ), a leader in cannabinoid-derive...

LOS ANGELES, CA / ACCESSWIRE / August 3, 2020 / The SNN Network Virtual Conference will take place on August 3 rd - 6 th , 2020, where 49 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. Kicking off the SNN Network Virtua...

Tetra Bio-Pharma Announces Expected Effective Date of Listing on TSX of its Common Shares and Warrants Canada NewsWire OTTAWA, ON, July 30, 2020 /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES / OTTAWA, ON , July 30, 20...

Resumption of its PLENITUDE© clinical trial on-time; CAUMZ™ manufacturing set to begin in USA to allow start of clinical trials; QIXLEEF™ metabolite mapping study to be complete in Q3 2020 OTTAWA / ACCESSWIRE / July 28, 2020 / Tetra Bio-Pharma Inc. ("Tetra...

OTTAWA, CANADA / ACCESSWIRE / July 27, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSXV: TBP ) (OTCQB: TBPMF ), a leader in cannabinoid-derived drug discovery and development, is providing its shareholders with a management update on the Company's Annual General Meeting (AGM) o...